INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 21 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $240,000 | +3.9% | 246,000 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $231,000 | -74.8% | 246,000 | -75.4% | 0.02% | -72.8% |
| Q1 2022 | $918,000 | +1.2% | 1,000,000 | 0.0% | 0.08% | +2.5% |
| Q3 2021 | $907,000 | +0.1% | 1,000,000 | 0.0% | 0.08% | -2.5% |
| Q2 2021 | $906,000 | +9.7% | 1,000,000 | 0.0% | 0.08% | -16.5% |
| Q1 2021 | $826,000 | +5.2% | 1,000,000 | 0.0% | 0.10% | +1.0% |
| Q4 2020 | $785,000 | -2.0% | 1,000,000 | 0.0% | 0.10% | -7.7% |
| Q3 2020 | $801,000 | – | 1,000,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
| Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
| PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
| Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
| DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
| WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |